0 Commentarii
0 Distribuiri
368 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
GLP-1 Receptor Agonists Obesity Drugs Market: Insights, Key Players, and Growth AnalysisAccording to the latest report published by Data Bridge Market Research, the GLP-1 Receptor Agonists Obesity Drugs Market CAGR Value The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032, at a CAGR of 16.21% during the forecast period Attaining...0 Commentarii 0 Distribuiri 388 Views 0 previzualizare
-
Peptide Drugs For Diabetes Market: GLP-1 Agonists and Injectable Segment Driving GrowthThe Peptide Drugs For Diabetes Market is experiencing significant and steady growth, with specific drug class and administration route segments acting as primary catalysts. The market, valued at USD 6.3 Billion in 2024, is projected to reach USD 11.2 Billion by 2032, driven by a global imperative for effective and comprehensive diabetes management. The GLP-1 agonists drug...0 Commentarii 0 Distribuiri 284 Views 0 previzualizare
-
Global Dual GIP/GLP-1 Receptor Agonists Obesity Drugs Market: Therapeutic Innovation, Obesity Treatment Trends, Demand, and Growth OutlookAccording to the latest report published by Data Bridge Market Research, the Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market CAGR Value The global dual GIP/ GLP-1 receptor agonists obesity drugs market size was valued at USD 4.75 billion in 2024 and is expected to reach USD 17.71 billion by 2032, at a CAGR of 17.85% during the forecast...0 Commentarii 0 Distribuiri 271 Views 0 previzualizare
-
Global Prefilled Syringes Market: Rising Demand for Biologics, GLP-1 Drugs, and Self-Administration Devices Creates New Growth Opportunities for Pharmaceutical Manufacturers and Medical Device Companies" According to the latest report published by Data Bridge Market Research, the Prefilled Syringes Market CAGR Value The global prefilled syringes market size was valued at USD 8.04 billion in 2024 and is expected to reach USD 16.63 billion by 2032, at a CAGR of 9.50% during the forecast period This Prefilled Syringes Marketresearch report is structured by performing the systematic,...0 Commentarii 0 Distribuiri 26 Views 0 previzualizare
-
GLP-1 Receptor Agonists Obesity Drugs Market: Insights, Key Players, and Growth AnalysisAccording to the latest report published by Data Bridge Market Research, the GLP-1 Receptor Agonists Obesity Drugs Market CAGR Value The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032, at a CAGR of 16.21% during the forecast period With the...0 Commentarii 0 Distribuiri 291 Views 0 previzualizare
-
GLP-1 Receptor Agonists Obesity Drugs Market: Insights, Key Players, and Growth AnalysisAccording to the latest report published by Data Bridge Market Research, the GLP-1 Receptor Agonists Obesity Drugs Market CAGR Value The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032, at a CAGR of 16.21% during the forecast period This...0 Commentarii 0 Distribuiri 251 Views 0 previzualizare
-
GLP-1 Receptor Agonists Obesity Drugs Market: Insights, Key Players, and Growth AnalysisAccording to the latest report published by Data Bridge Market Research, the GLP-1 Receptor Agonists Obesity Drugs Market The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032, at a CAGR of 16.21% during the forecast period CAGR Value With a...0 Commentarii 0 Distribuiri 312 Views 0 previzualizare
-
GLP-1 Receptor Agonists Obesity Drugs Market: Size, Share, and Future GrowthAccording to the latest report published by Data Bridge Market Research, the GLP-1 Receptor Agonists Obesity Drugs Market CAGR Value The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032, at a CAGR of 16.21% during the forecast period With the clear...0 Commentarii 0 Distribuiri 402 Views 0 previzualizare
-
Long-Acting GLP-1 Analogues Market Growth Rate, Revenue & Forecast 2033"Long-Acting GLP-1 Analogues Market Summary According to the latest report published by Data Bridge Market Research, the Long-Acting GLP-1 Analogues Market As per Data Bridge Market Research analysis, the long-acting GLP-1 analogues market was valued at USD 18.42 billion in 2025 and is projected to reach USD 39.77 billion by 2033, growing at a CAGR of 10.10% from 2026 to 2033. The wide...0 Commentarii 0 Distribuiri 96 Views 0 previzualizare
-
Long-Acting Implantable GLP-1 Obesity Devices Market Growth, In depth Studies with Top Vendors Analysis By FMINEWARK, DE |—The long-acting implantable GLP-1 obesity devices market is valued at USD 59.1 million in 2025 and is projected to reach USD 76.0 million in 2026. Expanding at a robust CAGR of 28.50%, the market is expected to surge to USD 932.9 million by 2036. This growth reflects a fundamental shift in obesity care delivery, as stakeholders prioritize long-term therapy...0 Commentarii 0 Distribuiri 403 Views 0 previzualizare
-
GLP-1 Receptor Agonist Market Trends in Advanced Biopharmaceutical DevelopmentThe global GLP-1 Receptor Agonist Market was valued at USD 66.4 billion in 2025 and is projected to grow from USD 82.0 billion in 2026 to USD 185.3 billion by 2033, registering a CAGR of 12.4% from 2026 to 2033. The market is witnessing remarkable growth due to the rising prevalence of type 2 diabetes, obesity, and other metabolic disorders, coupled with increasing clinical acceptance...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
-
GLP-1 Agonists Weight Loss Drugs Market Supply Chain AnalysisThe global GLP-1 Agonists Weight Loss Drugs Market was valued at USD 13.8 billion in 2024 and is projected to grow from USD 27.5 billion in 2026 to USD 48.8 billion by 2030, registering a CAGR of 18.5% from 2025 to 2030. North America dominated the market with a 75.5% revenue share in 2024, supported by high obesity prevalence, favorable reimbursement policies, strong pharmaceutical...0 Commentarii 0 Distribuiri 615 Views 0 previzualizare
-
Diabetes Treatments Market Size, Share, and Growth Forecast to 2030According to the latest report published by Data Bridge Market Research, the Diabetes Treatments Market Data Bridge Market Research analyses that the global diabetes treatments market which was USD 5,370.2 million in 2022, would rocket up to USD 8,920.9 million by 2030, and is expected to undergo a CAGR of 6.5 % during the forecast period. Type-1 segment dominates the type segment of...0 Commentarii 0 Distribuiri 6K Views 0 previzualizare
-
GLP-1 Market: Research Advancements and Industry DevelopmentsThe GLP-1 Market is expanding as therapeutic applications move beyond diabetes into obesity and cardiovascular disease. Valued at USD 52.82 billion in 2025, the GLP-1 Market is projected to reach USD 58.48 billion in 2026 and USD 133.92 billion by 2034, growing at a CAGR of 10.9% during the forecast period 2026–2034. Key players include AstraZeneca, Boehringer Ingelheim, D&D...0 Commentarii 0 Distribuiri 81 Views 0 previzualizare
-
Pen Needles Market: The Growing Importance of 4mm and 5mm NeedlesThe pen needles market is increasingly being shaped by a simple healthcare priority: making injectable therapies easier and more comfortable to manage. As diabetes prevalence continues to rise and more patients administer medications at home, Pen Needles Market are becoming an important part of everyday disease management. The global market was valued at USD 4.8 billion in 2025 and is projected...0 Commentarii 0 Distribuiri 66 Views 0 previzualizare
Sponsorizeaza Paginile
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek
Bengali